DGKα-IN-9
DGKα-IN-9 is a diacylglycerol kinase alpha (DGKα) inhibitor. DGKα-IN-9 demonstrates a tumor growth inhibition in MC38 or or CT26 mouse tumor model. DGKα-IN-9 can be used for the study of cancer[1].
Product Specifications
CAS Number
2980406-85-5
UNSPSC
12352005
Target
DGK
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
ClC1=CC2=C(N(C)C(N=C2N3C4=C(C(C#CC5(CC5)C(F)(F)F)=CC=C4)COCC3)=O)C=C1OCCO
Molecular Formula
C26H23ClF3N3O4
Molecular Weight
533.93
References & Citations
[1]SUN, Deheng, et al.COMBINATIONS TREATMENTS OF DIACYLGLYCEROL KINASE (DGK) ALPHA INHIBITORS AND OTHER THERAPIES.China, WO/2025/051110. 2025-03-13.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1293820-01 0.02 mg (E-Coli)
Recombinant Shigella dysenteriae serotype 1 Putative aminoacrylate hydrolase RutD (rutD)
Sign In for Pricing
View Details MBS1293820-02 0.1 mg (E-Coli)
Recombinant Shigella dysenteriae serotype 1 Putative aminoacrylate hydrolase RutD (rutD)
Sign In for Pricing
View Details MBS1293820-03 0.02 mg (Yeast)
Recombinant Shigella dysenteriae serotype 1 Putative aminoacrylate hydrolase RutD (rutD)
Sign In for Pricing
View Details